1. Home
  2. TTRX vs FCCO Comparison

TTRX vs FCCO Comparison

Compare TTRX & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$16.25

Market Cap

298.8M

Sector

Health Care

ML Signal

HOLD

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$33.81

Market Cap

320.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTRX
FCCO
Founded
2015
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
298.8M
320.5M
IPO Year
2025
2012

Fundamental Metrics

Financial Performance
Metric
TTRX
FCCO
Price
$16.25
$33.81
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$8.00
N/A
AVG Volume (30 Days)
91.4K
39.2K
Earning Date
05-31-2026
04-22-2026
Dividend Yield
N/A
2.16%
EPS Growth
N/A
36.46
EPS
N/A
1.39
Revenue
N/A
$922,000.00
Revenue This Year
N/A
$30.67
Revenue Next Year
N/A
$5.87
P/E Ratio
N/A
$24.32
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$25.92
52 Week High
$14.50
$35.74

Technical Indicators

Market Signals
Indicator
TTRX
FCCO
Relative Strength Index (RSI) 75.45 46.32
Support Level $3.49 $32.44
Resistance Level N/A $33.70
Average True Range (ATR) 1.31 0.79
MACD 0.32 -0.05
Stochastic Oscillator 88.29 39.32

Price Performance

Historical Comparison
TTRX
FCCO

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

Share on Social Networks: